Cystic Fibrosis and the TRIKAFTA Breakthrough: Results from the Triple-Combination Therapy Trials
Cystic fibrosis (CF) is a genetic disorder that impacts the cells that produce sweat, mucus, and digestive juices. Its manifestation primarily affects the respiratory and digestive systems, leading to persistent lung infections and nutritional challenges. The TRIKAFTA breakthrough, a novel medication approved by the FDA in 2019, has revolutionized the treatment landscape for people with […]